A Simulation of Strategies to Lower Bulk Tank Somatic Cell Count below 500,000 per Milliliter

Journal of Dairy Science

Volumn 81, Issue 3, 1998, Pages 694-702

  Allore, H G ^a   Erb, H N ^a   Schruben, L W ^a   Oltenacu, P A ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

Disease control; Mastitis; Simulation

Indexed keywords

ANTIINFECTIVE AGENT; LIPID; MILK PROTEIN;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; CATTLE; CATTLE DISEASE; CELL COUNT; CHEMISTRY; CYTOLOGY; FEMALE; HUMAN; LACTATION; MICROBIOLOGY; MILK; STAPHYLOCOCCUS INFECTION; STREPTOCOCCUS INFECTION;

ANIMALS; ANTI-BACTERIAL AGENTS; CATTLE; CELL COUNT; FEMALE; HUMANS; LACTATION; LIPIDS; MASTITIS, BOVINE; MILK; MILK PROTEINS; MODELS, BIOLOGICAL; STAPHYLOCOCCAL INFECTIONS; STREPTOCOCCAL INFECTIONS;

EID: 0032019924     PISSN: 00220302     EISSN: None     Source Type: Journal    
DOI: 10.3168/jds.S0022-0302(98)75625-5     Document Type: Article

References (18)

1. Allore, H. G. 1996. A methodology for assessing the effectiveness of mastitis-control strategies. Ph.D. Diss., Cornell Univ., Ithaca, NY.
2. Allore, H. G., P. A. Oltenacu, and R. Pearce. 1995. Impacts of impending somatic cell count limits on Northeast milk producers and processors. J. Dairy Sci. 78(Suppl. 1): 179.(Abstr.)
3. Allore, H. G., L. W. Schruben, H. N. Erb, and P. A. Oltenacu. 1998. Design and validation of a dynamic discrete-event stochastic simulation model of mastitis control in dairy herds. J. Dairy Sci. 81:703-717.
4. Dekkers, J.C.M., T. van Erp, and Y. H. Schukken. 1996. Economic benefits of reducing somatic cell count under the milk quality program of Ontario. J. Dairy Sci. 79:396-401.
5. Eberhart, R. J., and J. M. Buckalew. 1972. Evaluation of a hygiene and dry period therapy program for mastitis control. J. Dairy Sci. 55:1683-1691.
6. Harmon, R. J., W. L. Crist, R. W. Hemken, and B. E. Langlois. 1986. Prevalence of minor udder pathogens after intramammary dry treatment. J. Dairy Sci. 69:843-849.
7. Houben, E.H.P., A. A. Dijkhuizen, J.A.M. Arendonk, and R. Huirne. 1993. Short- and long-term production losses and repeatability of clinical mastitis in dairy cattle. J. Dairy Sci. 76: 2561-2578.
8. Kastenbaum, M. A., D. G. Hoel, and K. O. Bowman. 1970. Sample size requirements: one-way analysis of variance. Biometrika 57:421-430.
9. Kingwill, R. G. 1981. The NIRD-CVL mastitis control method. Pages 24-39 in Mastitis control and herd management. Tech. Bull. No. 4. A. J. Bramley, F. H. Dodd, and T. K. Griffin, ed. Natl. Inst. Res. Dairying-Hannah Res. Inst., Reading, England.
10. Law, A. M., and W. D. Kelton. 1991. Simulation Modeling and Analysis. 2nd ed. McGraw-Hill, Inc., New York, NY.
11. SAS/STAT® User's Guide: Statistics, Volume 2, Version 6 Edition. 1990. SAS Inst., Inc., Cary, NC.
12. Schruben, L. W. 1995. Graphical Simulation Modeling and Analysis: Using SIGMA for Windows. Boyd and Fraser Publ. Co., Danvers, MA.
13. Schruben, L. W., and B. H. Margolin. 1978. Psuedorandom number assignment in statistically designed simulation and distribution sampling experiments. J. Am. Stat. Assoc. 73: 504-520.
14. Sears, P. M. 1996. Total quality management: AABP clinical mastitis guidelines and evaluation records to make treatment decisions. Bovine Pract. 28:82-89.
15. Smith, K. L. 1996. The National Mastitis Council and the future of mastitis control and quality milk production. Pages 62-64 in Proc. Natl. Mastitis Council Reg. Mtg., Queretaro, Mexico. Natl. Mastitis Counc., Inc., Madison, WI.
16. Snedecor, G. W., and W. G. Cochran. 1989. Statistical Methods. 8th ed. Iowa State Univ. Press, Ames.
17. United States Food and Drug Administration. 1991. Grade "A" Pasteurized Milk Ordinance. Dep. of Health and Human Serv., Public Health Serv., FDA, Rockville, MD.
18. Wilson, D. J. 1996. Factors influencing therapy decisions in clinical cases of Gram-positive mastitis. Bovine Pract. 28:90-93.